Search Results - "Sussman, Robyn"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Delayed Accumulation of H3K27me3 on Nascent DNA Is Essential for Recruitment of Transcription Factors at Early Stages of Stem Cell Differentiation by Petruk, Svetlana, Cai, Jingli, Sussman, Robyn, Sun, Guizhi, Kovermann, Sina K., Mariani, Samanta A., Calabretta, Bruno, McMahon, Steven B., Brock, Hugh W., Iacovitti, Lorraine, Mazo, Alexander

    Published in Molecular cell (20-04-2017)
    “…Recruitment of transcription factors (TFs) to repressed genes in euchromatin is essential to activate new transcriptional programs during cell differentiation…”
    Get full text
    Journal Article
  5. 5

    Primary Pulmonary Myxoid Sarcoma and Myxoid Angiomatoid Fibrous Histiocytoma: A Unifying Continuum With Shared and Distinct Features by Gui, Hongxing, Sussman, Robyn T., Jian, Bo, Brooks, John S., Zhang, Paul J.L.

    Published in The American journal of surgical pathology (01-11-2020)
    “…Primary pulmonary myxoid sarcoma (PPMS) is a recently reported, exceedingly rare low-grade lung neoplasm characterized by reticular/lace-like growth of spindle…”
    Get full text
    Journal Article
  6. 6

    The Epigenetic Modifier Ubiquitin-specific Protease 22 (USP22) Regulates Embryonic Stem Cell Differentiation via Transcriptional Repression of Sex-determining Region Y-box 2 (SOX2) by Sussman, Robyn T., Stanek, Timothy J., Esteso, Paul, Gearhart, John D., Knudsen, Karen E., McMahon, Steven B.

    Published in The Journal of biological chemistry (16-08-2013)
    “…Pluripotent embryonic stem cells (ESCs) undergo self-renewal until stimulated to differentiate along specific lineage pathways. Many of the transcriptional…”
    Get full text
    Journal Article
  7. 7
  8. 8

    NTRK point mutations and their functional consequences by Rogers, Corey, Morrissette, Jennifer J.D., Sussman, Robyn T.

    Published in Cancer genetics (01-04-2022)
    “…•NTRK point mutations can be oncogenic driver or acquired resistance mutations.•Some point mutations in NTRK genes respond to targeted…”
    Get full text
    Journal Article
  9. 9

    Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms by Sussman, Robyn T, Oran, Amanda R, Paolillo, Carmela, Lieberman, David, Morrissette, Jennifer J D, Rosenbaum, Jason N

    “…Next-generation sequencing is a high-throughput method for detecting genetic abnormalities and providing prognostic and therapeutic information for patients…”
    Get full text
    Journal Article
  10. 10

    Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice by Davis, Adam R., Stone, Sara L., Oran, Amanda R., Sussman, Robyn T., Bhattacharyya, Siddharth, Morrissette, Jennifer J.D., Bagg, Adam

    Published in Modern pathology (01-05-2021)
    “…Massively parallel sequencing (MPS) has become a viable diagnostic tool to interrogate genetic profiles of numerous tumors but has yet to be routinely adopted…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Epigenomic profiling of neuroblastoma cell lines by Upton, Kristen, Modi, Apexa, Patel, Khushbu, Kendsersky, Nathan M., Conkrite, Karina L., Sussman, Robyn T., Way, Gregory P., Adams, Rebecca N., Sacks, Gregory I., Fortina, Paolo, Diskin, Sharon J., Maris, John M., Rokita, Jo Lynne

    Published in Scientific data (14-04-2020)
    “…Understanding the aberrant transcriptional landscape of neuroblastoma is necessary to provide insight to the underlying influences of the initiation,…”
    Get full text
    Journal Article
  15. 15

    CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma by Sussman, Robyn T, Rokita, Jo Lynne, Huang, Kevin, Raman, Pichai, Rathi, Komal S, Martinez, Daniel, Bosse, Kristopher R, Lane, Maria, Hart, Lori S, Bhatti, Tricia, Pawel, Bruce, Maris, John M

    Published in Frontiers in oncology (06-03-2020)
    “…We developed a computational pipeline designed to use RNA sequencing ( = 136) and gene expression profiling ( = 250) data from neuroblastoma tumors to identify…”
    Get full text
    Journal Article
  16. 16

    Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes by Feng, Yang, Wang, Yanping, Zhu, Zhongyu, Li, Wei, Sussman, Robyn T, Randall, Michael, Bosse, Kristopher R, Maris, John M, Dimitrov, Dimiter S

    Published in mAbs (18-05-2016)
    “…CD56 (NCAM, neural cell adhesion molecule) is over-expressed in many tumor types, including neuroblastoma, multiple myeloma, small cell lung cancer, ovarian…”
    Get full text
    Journal Article
  17. 17

    Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AML by Sussman, Robyn T., Manning, Bryan, Ackerman, Daniel, Bigdeli, Ashkan, Pammer, Paige, Velu, Priya D., Luger, Selina M., Bagg, Adam, Carroll, Martin, Morrissette, Jennifer J.D.

    Published in Cancer genetics (01-08-2021)
    “…•Correlation of cytogenetic prognostic risk stratification with mutations in newly diagnosed de novo Acute Myeloid Leukemia.•Correlation of cytogenetic…”
    Get full text
    Journal Article
  18. 18

    Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the Non-SP, a higher expression of c-Myc and TRAIL-receptor DR4 by Sussman, Robyn T., Ricci, M. Stacey, Hart, Lori S., Sun, Shi Yong, El-Deiry, Wafik S.

    Published in Cancer biology & therapy (01-09-2007)
    “…Cancer stem cells are resistant to chemotherapy and provide an important target for drug development. We found that, surprisingly, the dye-effluxing side…”
    Get full text
    Journal Article
  19. 19

    Validation of a next-generation sequencing oncology panel optimized for low input DNA by Sussman, Robyn T., Shaffer, Sydney, Azzato, Elizabeth M., DeSloover, Daniel, Farooqi, Midhat S., Meyer, Anders, Lieberman, David B., Bigdeli, Ashkan, Paolillo, Carmela, Ganapathy, Karthik, Sukhadia, Shrey, Rosenbaum, Jason N., Daber, Robert D., Morrissette, Jennifer J.D.

    Published in Cancer genetics (01-12-2018)
    “…•Hotspot panel for poor quality and low input oncology specimens.•Assay input DNA as low as 0.5-1 ng. One caveat of next-generation sequencing (NGS)-based…”
    Get full text
    Journal Article
  20. 20